APACHE Medical Systems Makes GSA Schedules for IT Systems and Services.

Business Editors/Health & Medical Writers

MCLEAN, Va.--(BW HealthWire)--March 2, 2001

APACHE Medical Systems, Inc. (Nasdaq:AMSI), today announced that the Company has been placed on the GSA (General Services Administration) Schedules for both information technology systems and consulting services, allowing the Company to sell directly to federal government agencies as a prime vendor. APACHE has been added to Schedule 70 for General Purpose Commercial Information Technology Equipment, Software, and Services, and to Schedule 874 for Management, Organization, and Business Improvement Services (MOBIS). GSA Schedules make it easy and less expensive for federal government agencies to obtain commercial products and services by decreasing acquisition time and cutting through red tape.

"Placement on the GSA Schedules opens the door for APACHE to substantially increase our presence in the federal healthcare sector," said APACHE President and COO, Violet L. Shaffer. "It gives us a distinct advantage in marketing to VA and US military hospitals, and was a key short-term objective for our Federal initiative." APACHE announced a new focus on the federal market last year.

APACHE is currently conducting a bed allocation study for Hines VA in Chicago, and continues its work with the US Centers for Disease Control and Prevention (CDC) for the CDC's HIV Outpatient Study, as well as a related study investigating hepatitis and influenza in HIV-positive patients.

About APACHE

APACHE Medical Systems, Inc.--a recognized leader in clinical decision support/outcomes management systems and consulting services for the care of high-risk patients--provides products and services that enable health systems, hospitals and providers to apply an evidence-based approach to achieve clinical performance excellence, reduce cost and compete effectively under managed care. APACHE is helping providers better manage the clinical, financial and patient outcomes of high-risk, high-cost patients in critical, acute, cardiovascular and HIV/AIDS care. APACHE provides advanced clinical data collection tools, registry management and analytic services for federal government research, as well as in support of clinical trial design and product-effectiveness evaluations for the pharmaceutical and medical device industries.

APACHE (www.apache-msi.com) is headquartered in Northern Virginia.

Statements in this press release that are not historical facts are forward-looking statements under provisions of the Private Securities Litigation Reform Act of 1995. All forward-looking statements involve risks and uncertainties. The Company wishes to caution readers that the following important factors, among others, in some cases have affected, and in the future could affect, the Company's actual results and could cause its actual results in fiscal 2000 and beyond to differ materially from those expressed in any forward-looking statements made by, or on behalf of the Company.

Important factors that could cause actual results to differ materially include but are not limited to the Company's having sufficient sales and timely collections to meet cash requirements and achieve profitability; ability to attract and retain key employees; success of its strategy to concentrate its product offerings on high-risk, high-cost patients; ability to timely develop new products and enhance existing products; ability to compete in the competitive and rapidly evolving healthcare information technology industry; ability to correctly estimate and manage its Year 2000 costs and liabilities; success of its marketing and consulting efforts and ability to effectively utilize its direct sales force; ability to protect proprietary information and to obtain necessary licenses on commercially reasonable terms; and ability to comply with and adapt products and services to potential regulatory changes.